UPDATE: Baird Downgrades Vir Biotechnology (VIR) to Underperform
Tweet Send to a Friend
(Updated - February 27, 2020 8:14 AM EST)
(updating comment)Baird analyst Madhu Kumar downgraded Vir Biotechnology (NASDAQ: VIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Baird analyst Madhu Kumar downgraded Vir Biotechnology (NASDAQ: VIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
